START Midwest Cancer and Hematology Centers of W Michigan — Grand Rapids, Michigan

START Midwest Cancer and Hematology Centers of W Michigan is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

START Midwest Cancer and Hematology Centers of W Michigan has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor.

Sponsors: Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Grand Rapids

Browse all research sites in Michigan · View every site in Grand Rapids

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Midwest Cancer and Hematology Centers of W Michigan?

START Midwest Cancer and Hematology Centers of W Michigan has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Midwest Cancer and Hematology Centers of W Michigan conducted?

START Midwest Cancer and Hematology Centers of W Michigan has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor.

Is START Midwest Cancer and Hematology Centers of W Michigan accredited by Crixeo Clinical Trials?

START Midwest Cancer and Hematology Centers of W Michigan has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Midwest Cancer and Hematology Centers of W Michigan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.